Pressure BioSciences Inc. (PBIO) Delivers Custom B
Post# of 1354
(Total Views: 356)
Posted On: 07/17/2019 5:11:52 PM
Pressure BioSciences Inc. (PBIO) Delivers Custom Built, Proprietary Ultra Sheer Technology Instrument to Ohio State for Food Safety Research
- PBIO’s proprietary Ultra Sheer Technology (“UST”) platform can be used to create the higher quality, more nutritious, longer-lasting, chemical-free foods that consumers demand
- Recent delivery of a working benchtop UST instrument to Ohio State scientists marks the first major milestone in a nearly $1 million federally funded collaborative study
- Separate from the collaboration between PBIO and OSU in the liquid food (primarily dairy) area, PBIO’s UST platform, which has been proven to create high quality, visually clear nanoemulsion mixtures of oil and water, has the potential to play a critical role in pharmaceuticals, cosmetics, and nutraceuticals
- The company recently announced its entry into the cannabis marketplace with a major focus in the CBD area; its new UST-based instrument can make CBD oil water-soluble, increasing its absorption and bioavailability
Foodborne illnesses are a costly, common public health problem. Researchers have identified more than 250 foodborne diseases, with 48 million people a year falling ill after consuming contaminated foods or beverages, according to the U.S. Centers for Disease Control and Prevention (http://nnw.fm/Rhd2I). Of those who get sick, 128,000 are hospitalized, and 3,000 die. “Do I have food poisoning?” is a very common expression and one of the first thoughts people express when they worry about whether they’ve been infected by a foodborne infection.
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, has developed a proprietary Ultra Sheer Technology (“UST”) platform that can be used to increase food safety while retaining – sometimes even improving – the nutrition, flavor and quality of food.
Dr. Edmund Y. Ting, senior vice president of engineering at PBI, sees the company’s collaborative research in this space with Ohio State University as a gamechanger for the food science industry. PBIO recently delivered a working benchtop UST instrument to Ohio State scientists who are studying pressure and shear effects on pathogen inactivation, stability and quality of food.
“We believe our proprietary UST platform can be used to make the higher quality, more nutritious, longer-lasting foods that consumers now demand,” Dr. Ting stated in a news release. “The UST-based benchtop instrument – together with the larger scale, floor model, higher capacity instrument we are now developing – will be used to generate the fundamental food science quality and safety validation data that we believe will enable future process adoption by industry and acceptance by the regulators.”
PBIO’s collaboration with the College of Food, Agricultural and Environmental Sciences at Ohio State is funded through a four-year, $891,000 grant awarded by the U.S. Department of Agriculture’s National Institute of Food and Agriculture. PBIO was granted a $318,000 sub-contract to build a working benchtop instrument, which was delivered June 26, and a pilot plant floor model, both based on the company’s patented UST platform.
The program’s primary goal is to develop and make available for commercialization a continuous-flow manufacturing process to prepare foods and beverages with superior nutritional and sensory qualities and long, room temperature shelf stability without the requirement for refrigeration or chemical additives. It’s a lucrative field, with the global high pressure processing (“HPP”) food market estimated to reach $27.4 billion in 2023 and surpass $51 billion by 2027, according to an article on FoodSafetyTech.com (http://nnw.fm/YE4e5).
There are other important applications for PBIO’s proprietary platform, including the unique purpose of creating high quality nanoemulsions of cannabidiol (CBD) oil in water. Independent test results have shown that these CBD oil nanoemulsions retain nearly 100 percent of the CBD molecule after processing, without altering the molecule or generating impurities. The company recently announced its entry into the cannabis marketplace with a major focus on the CBD market (http://nnw.fm/Gr7D4).
The company’s patented UST platform can process CBD plant oil into water-soluble nanoemulsions, which can then be completely dissolved in different liquids, such as soft drinks and beer. This process is discussed in two short videos (http://nnw.fm/2qOQV and http://nnw.fm/opQ3D) as a laboratory technician shows the viewer how the UST technology works.
The company believes that the potential for the UST platform to impact the CBD industry is promising, with the total cannabinoid market expected to hit $22 billion by 2022 as CBD oil-based supplements form the cornerstone of the market (http://nnw.fm/dd6Aw). Notably, while CBD is an attractive opportunity for PBI’s proprietary UST platform, the nutraceuticals, topicals and cosmetics, and food and beverage markets, as mentioned, could be 10-50 times larger.
Contaminated consumer products are a growing risk with nationwide recall notices becoming commonplace. PBIO believes that its proprietary Ultra Shear Technology can help a diverse variety of customers to develop a vast array of new and beneficial products spanning multiple large markets, including CBD and nutraceuticals, cosmetics and topicals, food and beverages, drug delivery and more.
For more information, visit the company’s website at www.PressureBioSciences.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- PBIO’s proprietary Ultra Sheer Technology (“UST”) platform can be used to create the higher quality, more nutritious, longer-lasting, chemical-free foods that consumers demand
- Recent delivery of a working benchtop UST instrument to Ohio State scientists marks the first major milestone in a nearly $1 million federally funded collaborative study
- Separate from the collaboration between PBIO and OSU in the liquid food (primarily dairy) area, PBIO’s UST platform, which has been proven to create high quality, visually clear nanoemulsion mixtures of oil and water, has the potential to play a critical role in pharmaceuticals, cosmetics, and nutraceuticals
- The company recently announced its entry into the cannabis marketplace with a major focus in the CBD area; its new UST-based instrument can make CBD oil water-soluble, increasing its absorption and bioavailability
Foodborne illnesses are a costly, common public health problem. Researchers have identified more than 250 foodborne diseases, with 48 million people a year falling ill after consuming contaminated foods or beverages, according to the U.S. Centers for Disease Control and Prevention (http://nnw.fm/Rhd2I). Of those who get sick, 128,000 are hospitalized, and 3,000 die. “Do I have food poisoning?” is a very common expression and one of the first thoughts people express when they worry about whether they’ve been infected by a foodborne infection.
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, has developed a proprietary Ultra Sheer Technology (“UST”) platform that can be used to increase food safety while retaining – sometimes even improving – the nutrition, flavor and quality of food.
Dr. Edmund Y. Ting, senior vice president of engineering at PBI, sees the company’s collaborative research in this space with Ohio State University as a gamechanger for the food science industry. PBIO recently delivered a working benchtop UST instrument to Ohio State scientists who are studying pressure and shear effects on pathogen inactivation, stability and quality of food.
“We believe our proprietary UST platform can be used to make the higher quality, more nutritious, longer-lasting foods that consumers now demand,” Dr. Ting stated in a news release. “The UST-based benchtop instrument – together with the larger scale, floor model, higher capacity instrument we are now developing – will be used to generate the fundamental food science quality and safety validation data that we believe will enable future process adoption by industry and acceptance by the regulators.”
PBIO’s collaboration with the College of Food, Agricultural and Environmental Sciences at Ohio State is funded through a four-year, $891,000 grant awarded by the U.S. Department of Agriculture’s National Institute of Food and Agriculture. PBIO was granted a $318,000 sub-contract to build a working benchtop instrument, which was delivered June 26, and a pilot plant floor model, both based on the company’s patented UST platform.
The program’s primary goal is to develop and make available for commercialization a continuous-flow manufacturing process to prepare foods and beverages with superior nutritional and sensory qualities and long, room temperature shelf stability without the requirement for refrigeration or chemical additives. It’s a lucrative field, with the global high pressure processing (“HPP”) food market estimated to reach $27.4 billion in 2023 and surpass $51 billion by 2027, according to an article on FoodSafetyTech.com (http://nnw.fm/YE4e5).
There are other important applications for PBIO’s proprietary platform, including the unique purpose of creating high quality nanoemulsions of cannabidiol (CBD) oil in water. Independent test results have shown that these CBD oil nanoemulsions retain nearly 100 percent of the CBD molecule after processing, without altering the molecule or generating impurities. The company recently announced its entry into the cannabis marketplace with a major focus on the CBD market (http://nnw.fm/Gr7D4).
The company’s patented UST platform can process CBD plant oil into water-soluble nanoemulsions, which can then be completely dissolved in different liquids, such as soft drinks and beer. This process is discussed in two short videos (http://nnw.fm/2qOQV and http://nnw.fm/opQ3D) as a laboratory technician shows the viewer how the UST technology works.
The company believes that the potential for the UST platform to impact the CBD industry is promising, with the total cannabinoid market expected to hit $22 billion by 2022 as CBD oil-based supplements form the cornerstone of the market (http://nnw.fm/dd6Aw). Notably, while CBD is an attractive opportunity for PBI’s proprietary UST platform, the nutraceuticals, topicals and cosmetics, and food and beverage markets, as mentioned, could be 10-50 times larger.
Contaminated consumer products are a growing risk with nationwide recall notices becoming commonplace. PBIO believes that its proprietary Ultra Shear Technology can help a diverse variety of customers to develop a vast array of new and beneficial products spanning multiple large markets, including CBD and nutraceuticals, cosmetics and topicals, food and beverages, drug delivery and more.
For more information, visit the company’s website at www.PressureBioSciences.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼